Tesamorelin Peptide

What is TSM10?

GHRH analog profile associated with visceral-fat and GH-axis research. The LPPEPTIDE knowledge record describes Tesamorelin as a synthetic 44-amino-acid GHRH analog that stimulates endogenous GH release, raises IGF-1 markers, and is approved for reducing visceral adipose tissue in HIV-associated lipodystrophy. Tesamorelin 10mg is mapped to LPPeptide SKU TSM10. Current storefront values use our product data: 10mg x 10 vials /box, $169.00 USD per box. LPPeptide reference specs: 5mg x 10 vials / 10mg x 10 vials.

Research context

The Core PEPTIDE knowledge record describes Tesamorelin as a synthetic 44-amino-acid GHRH analog that stimulates endogenous GH release, raises IGF-1 markers, and is approved for reducing visceral adipose tissue in HIV-associated lipodystrophy. Research usually focuses on GHRH receptor signaling, pulsatile GH release, IGF-1 pathway markers, and metabolic endpoint tracking.

Commonly matched with

TSM10 is commonly reviewed alongside RT10, RT20, RT30, TR10, Sermorelin. Keep each combination tied to a defined research objective and lot record.

Compliance notice

TSM10 is supplied for research use only. It is not for human or veterinary use, not for consumption, and statements on this page are reference context rather than medical claims.

Reference literature focus

The Core PEPTIDE knowledge record describes tesamorelin as a synthetic 44-amino-acid GHRH analog that stimulates endogenous GH release, raises IGF-1 markers, and is approved for reducing visceral adipose tissue in HIV-associated lipodystrophy. Research usually focuses on GHRH receptor signaling, pulsatile GH release, IGF-1 pathway markers, and metabolic endpoint tracking.

Study design notes

Use the Core Peptide product knowledge record, current Core Peptide COA, and internal lab SOP to confirm identity, concentration, and endpoints before this material enters a study. The matched LPPeptide reference specification is 5mg x 10 vials / 10 mg x 10 vials.

Core PEPTIDE knowledge source: add 2.0 mL bacteriostatic water per 10 mg vial for 5.0 mg/mL. The standard reference amount is 2 mg once daily. At 5.0 mg/mL, 1 U equals 50 mcg.

Core PEPTIDE preparation pattern: use sterile technique, add diluent slowly down the vial wall, avoid foaming, roll gently until dissolved, label the preparation date, refrigerate at 2-8°C, and protect from light.

Preparation

Tesamorelin 10 mg ships as lyophilized powder. Reconstitution note: Core PEPTIDE knowledge source: add 2.0 mL bacteriostatic water per 10 mg vial for 5.0 mg/mL. The standard reference amount is 2 mg once daily. At 5.0 mg/mL, 1 U equals 50 mcg. Record the final concentration and preparation date in the study log.

Storage

Lyophilized: 2-8°C. Reconstituted with bacteriostatic water at 2-8°C and used within 7 days. Do not freeze the prepared solution. Follow the most current lot-specific handling record whenever it is available.

Safety observations

Commonly reviewed signals include fluid retention, glucose markers, injection-site response, and GH-axis sensitivity.

Contraindications

Do not use TSM10 outside qualified research workflows. Review the current SDS, COA, and protocol exclusions before handling.

Interaction review

Review combinations with sermorelin, CJC-1295, ipamorelin, IGF-axis materials, or glucose-pathway compounds.

Certificate of Analysis

Each Core Peptide lot should be confirmed against current batch documentation before shipment or study use. This product page keeps TSM10 visible so the SKU can be matched to the active COA.

Current catalog summary

• SKU: TSM10
• Product: Tesamorelin 10 mg
• Storefront specification: 10 mg x 10 vials / box
• Core Peptide reference specs: 5 mg x 10 vials / 10 mg x 10 vials
• Listed box price: $169.00 USD
• Reference: Core Peptide product knowledge record

Testing checklist

• Peptide identity or material identity
• HPLC purity or assay result where applicable
• Batch ID and test date
• Sterility/endotoxin or accessory checks when applicable
• Residual solvent and handling notes where applicable